Literature DB >> 7582537

Characterization of nitrergic neurotransmission during short- and long-term electrical stimulation of the rabbit anococcygeus muscle.

L Kasakov1, S Cellek, S Moncada.   

Abstract

1. Isolated preparations of rabbit anococcygeus muscle were exposed to electrical field stimulation (EFS; 50V, 0.3 ms duration, 0.08-40 Hz) for periods of 1-60 s (short-term EFS) or 10 min-2 h (long-term EFS). 2. Both short- and long-term EFS caused a contractile response which was enhanced by the nitric oxide (NO) synthase inhibitor, NG-nitro-L-arginine (L-NOARG), showing that it is modulated by endogenous NO. 3. In preparations treated with scopolamine and guanethidine and in which a constrictor tone was induced by histamine, both short- and long-term EFS resulted in relaxation of the tissue. 4. Such relaxations were reversed by tetrodotoxin (TTX), omega-conotoxin, inhibitors of NO synthase and the NO scavenger, oxyhaemoglobin, indicating that they are neuronal in origin and nitrergic in nature. 5. The relaxations to long-term EFS persisted for the duration of the stimulation and were associated with sustained release of oxidation products of NO (NOx). The EFS-induced release of NOx was decreased by N-iminoethyl-L-ornithine (L-NIO), an inhibitor of NO synthase, and by TTX. 6. Inhibitors of NO synthase, in addition, increased the basal tone of the tissue and reduced the basal output of NOx. The basal output of NOx was also reduced by TTX. 7. Long-term EFS which induces approximately 50% of the maximum relaxation could be enhanced by addition of L-, but not D-, arginine to the perfusion medium. 8. These data show that there is a continuous basal release of NO from nitrergic nerve terminals which maintains a relaxant tone in the rabbit anococcygeus muscle. 9. In addition, NO is released during short- and long-term EFS which further relaxes the preparation and modulates sympathetic transmission. Activation of the L-argimne: NO pathway for periods up to2 h does not exhaust nitrergic transmission in any appreciable way.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7582537      PMCID: PMC1908775          DOI: 10.1111/j.1476-5381.1995.tb15017.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  28 in total

1.  Role of nitric oxide in non-adrenergic, non-cholinergic inhibitory junction potentials in canine ileocolonic sphincter.

Authors:  S M Ward; E S McKeen; K M Sanders
Journal:  Br J Pharmacol       Date:  1992-04       Impact factor: 8.739

2.  Stimulation of nitric oxide from muscle cells by VIP: prejunctional enhancement of VIP release.

Authors:  J R Grider; K S Murthy; J G Jin; G M Makhlouf
Journal:  Am J Physiol       Date:  1992-04

3.  Effects of omega-conotoxin GVIA on autonomic neuroeffector transmission in various tissues.

Authors:  A De Luca; C G Li; M J Rand; J J Reid; P Thaina; H K Wong-Dusting
Journal:  Br J Pharmacol       Date:  1990-10       Impact factor: 8.739

4.  Evidence for nitric oxide as an inhibitory neurotransmitter in rabbit isolated anococcygeus.

Authors:  A M Graham; P Sneddon
Journal:  Eur J Pharmacol       Date:  1993-06-11       Impact factor: 4.432

5.  Release of nitric oxide evoked by nerve stimulation in guinea-pig intestine.

Authors:  N P Wiklund; A M Leone; L E Gustafsson; S Moncada
Journal:  Neuroscience       Date:  1993-04       Impact factor: 3.590

6.  Modulation of neuroeffector transmission in the guinea pig pulmonary artery by endogenous nitric oxide.

Authors:  B Cederqvist; N P Wiklund; M G Persson; L E Gustafsson
Journal:  Neurosci Lett       Date:  1991-06-10       Impact factor: 3.046

7.  Nitric oxide synthase from cerebellum catalyzes the formation of equimolar quantities of nitric oxide and citrulline from L-arginine.

Authors:  P A Bush; N E Gonzalez; J M Griscavage; L J Ignarro
Journal:  Biochem Biophys Res Commun       Date:  1992-06-30       Impact factor: 3.575

Review 8.  Nitrergic transmission: nitric oxide as a mediator of non-adrenergic, non-cholinergic neuro-effector transmission.

Authors:  M J Rand
Journal:  Clin Exp Pharmacol Physiol       Date:  1992-03       Impact factor: 2.557

Review 9.  Nitric oxide as a mediator of nonadrenergic noncholinergic neurotransmission.

Authors:  K M Sanders; S M Ward
Journal:  Am J Physiol       Date:  1992-03

10.  Nitric oxide and vasoactive intestinal polypeptide mediate non-adrenergic, non-cholinergic inhibitory transmission to smooth muscle of the rat gastric fundus.

Authors:  C G Li; M J Rand
Journal:  Eur J Pharmacol       Date:  1990-12-04       Impact factor: 4.432

View more
  4 in total

1.  Nitrergic control of peripheral sympathetic responses in the human corpus cavernosum: a comparison with other species.

Authors:  S Cellek; S Moncada
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

2.  Selective nitrergic neurodegeneration in diabetes mellitus - a nitric oxide-dependent phenomenon.

Authors:  S Cellek; J Rodrigo; E Lobos; P Fernández; J Serrano; S Moncada
Journal:  Br J Pharmacol       Date:  1999-12       Impact factor: 8.739

3.  Endothelin-1 induces vasodilation in human skin by nociceptor fibres and release of nitric oxide.

Authors:  R R Wenzel; S Zbinden; G Noll; B Meier; T F Lüscher
Journal:  Br J Clin Pharmacol       Date:  1998-05       Impact factor: 4.335

4.  Inhibition of nitrergic relaxations by a selective inhibitor of the soluble guanylate cyclase.

Authors:  S Cellek; L Kasakov; S Moncada
Journal:  Br J Pharmacol       Date:  1996-05       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.